Charles L. Daley, M.D.

Dr. Daley is Professor of Medicine at National Jewish Health (NJH) and the University of Colorado Denver. He is Chief of the Division of Mycobacterial and Respiratory Infections and Director of the Nontuberculous Mycobacteria (NTM) Center of Excellence at NJH.

Dr. Daley works closely with the World Health Organization (WHO) and the Stop TB Partnership in the global control of drug-resistant tuberculosis. He is immediate past-Chair of the Strategic and Technical Advisory Group (STAG)-TB for WHO and Chair of the Global Drug Resistance Initiative, a working group of the Stop TB Partnership and advisory body to the WHO Global TB Department. He has served on expert panels for the WHO, Centers for Disease Control and American Thoracic Society: He is Chair of the ATS/IDSA/ERS/ESCMID NTM Guidelines revision committee and serves on the guideline committees for the diagnosis of TB, treatment of TB and treatment of MDR-TB for both the ATS and WHO.

Dr. Daley has been recognized as one of the “Best Doctors in America” by U.S. News & World Report and Castle Connolly and he recently received the World Lung Health Award given by the ATS. Dr. Daley was previously Associate Editor of the American Journal of Respiratory and Critical Care Medicine and currently Associate Editor of The European Respiratory Journal. His academic interests include global health policy and clinical and translational research in tuberculosis and NTM.